NCT02264873 2018-10-15Phase I, Dose Escalation Study of DecitabineUniversity of FloridaPhase 1 Completed3 enrolled
NCT00002980 2013-02-15Decitabine in Treating Patients With Melanoma or Other Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT00114257 2013-02-11Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative DisordersNational Cancer Institute (NCI)Phase 1 Completed36 enrolled
NCT00357708 2013-01-07Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other DiseasesNational Cancer Institute (NCI)Phase 1 Completed50 enrolled
NCT00002832 2012-07-30Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Completed14 enrolled